PROPANC BIOPHARMA, INC. Lessee, Operating Lease, Liability, to be Paid
PROPANC BIOPHARMA, INC. (PPCB) had Lessee, Operating Lease, Liability, to be Paid of $53.59 thousand as of 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-07-17
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid $53.59K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $56.85K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $62.58K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid $59.41K.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2026-03-31 | $53.59K S-1 · filed 2026-07-17 |
| 2025-12-31 | $56.85K S-1 · filed 2026-04-10 |
| 2025-09-30 | $62.58K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $59.41K S-1 · filed 2026-07-17 |
| 2025-03-31 | $1.86K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $7.30K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $14.19K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $19.36K 10-K · filed 2024-09-30 |
| 2024-03-31 | $24.27K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $30.92K 10-Q · filed 2024-02-20 |
| 2023-09-30 | $34.31K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $40.78K 10-K · filed 2023-09-28 |
| 2023-03-31 | $46.12K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $51.99K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $53.88K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $62.92K 10-K · filed 2022-09-28 |
| 2020-03-31 | $29.60K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $38.24K 10-Q · filed 2020-02-14 |
| 2019-09-30 | $42.81K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |